Summary by Futu AI
JUN SHENG TAI PHARMACEUTICAL-B (02511.HK) FILED ITS LATEST SECURITIES CHANGE MONTH REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON MAY 2, 2024, REPORTING CHANGES IN THE COMPANY'S SHARE CAPITAL AS OF APRIL 30, 2024. THE REPORT SHOWS THAT THE STATUTORY/REGISTERED SHARE CAPITAL AND ISSUED SHARES WERE UNCHANGED DURING THE REPORTING PERIOD. THE STATUTORY/REGISTERED SHARE CAPITAL WAS 1,000,000,000 SHARES WITH A FACE VALUE OF $0.0001 AND THE TOTAL REMAINED AT $100,000. In addition, the report confirms that the securities issued by the company this month have been formally authorized by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited. Dr. Liu Liping, Executive Director and Chief Executive Officer, is the submitter of this report.